Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Hiro

85 results about "Menstrual fluid" patented technology

Sanitary absorbent article with positioning flaps capable of gathering the undergarment to protect against wetting

InactiveUS20010009992A1Enhanced protection against undergarment wettingEasy to mass produceSanitary towelsBaby linensEngineeringWetting
The present invention relates to a sanitary absorbent article such as a sanitary napkin that has the ability to protect the undergarment of the wearer from being soiled by menstrual liquid. The sanitary napkin has a main body with panels that originate from its longitudinal side edges. A distal end of each panel that is continuous with the respective longitudinal side edge is folded underneath and affixed to the barrier later of the main body to form a looping member and a freely extending flap. As a result the effective affixation point of each flap is located inwardly of the respective side edge of the main body.
Owner:JOHNSON & JOHNSON INC QUEBEC

Dimensionally optimized menstrual fluid management device

The present invention relates to a menstrual fluid management device that is attached directly to the wearer by use of an adhesive. The device allows for direct and immediate containment of menstrual and other vaginal discharges. In particular, the device improves the prevention of soiling over devices already known in the art by using an attachment flange around an orifice which has a shape of the generally oblong dimensions, where the width in the rear end of the orifice is wider than at the front end, thereby improving the circumscription of the female genitalia and the sealing along the flange to the skin of the wearer.
Owner:THE PROCTER & GAMBLE COMPANY

Cellular therapeutic agent for incontinence or urine comprising stem cells originated from decidua or adipose

InactiveUS20110059052A1Preventing and treating urinary incontinencePreventing and urinary incontinenceBiocideMuscular disorderLeak point pressureUrethral sphincter
The present invention relates to a cellular therapeutic agent for treating urinary incontinence, and more particularly to a cellular therapeutic agent for treating urinary incontinence, which contains stem cells derived from the decidua of the placenta or menstrual fluid or stem cells derived from adipose. The decidua-derived stem cells or adipose-derived stem cells show the effects of increasing leak point pressure and urethral sphincter contractility, and thus are useful as an agent for treating urinary incontinence.
Owner:RNL BIO
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products